Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol) in Healthy Subjects
Unknown Phase 1 NCT06180070
Study Description
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Ibuprofen/ Paracetamol tablets (200mg Ibuprofen/ 500mg Paracetamol) versus Nuromol® tablets (200mg Ibuprofen/ 500mg Paracetamol) in healthy subjects under fasting condition.
Study Details
- Registry ID:
- NCT06180070
- Conditions:
- Migraine, Headache, Backache
- Phase:
- Phase 1
- Target Enrollment:
- 36 participants
- Start Date:
- Age Range:
- 18–50 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
ACDIMA Biocenter
Amman, Jordan
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.